Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, Álmos Klekner et al.|Journal of Clinical Oncology|2013Cited by 488
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Michael D. Taylor, Marc Remke et al.|The Lancet Oncology|2013Cited by 404
Subtype-specific expression and genetic alterations of the chemokinereceptor geneCXCR4 in medulloblastomasUlrich Schüller, Torsten Pietsch|International Journal of Cancer|2005Cited by 49
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular featuresMatthias Dottermusch, Ulrich Schüller|Acta Neuropathologica|2024Cited by 38
Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS NeuroblastomasTill Holsten, Ulrich Schüller|Journal of Neuropathology & Experimental Neurology|2020Cited by 35